Chemical Structure : JD-5037
CAS No.: 1392116-14-1
Catalog No.: PC-45531Not For Human Use, Lab Use Only.
JD-5037 is a potent, selective and peripherally restricted cannabinoid-1 (CB1) receptor blocker with IC50 of 2 nM, does not inhibit CB2 receptor (IC50>1000 nM).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $78 | In stock | |
10 mg | $118 | In stock | |
25 mg | $198 | In stock | |
50 mg | $298 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
JD-5037 is a potent, selective and peripherally restricted cannabinoid-1 (CB1) receptor blocker with IC50 of 2 nM, does not inhibit CB2 receptor (IC50>1000 nM).
JD-5037 was also characterized as an inverse agonist in forskolin-stimulated CHO cells over- expressing CB1-receptors by its ability to affect cAMP with EC50 of 46 nM.
JD-5037 showed little brain presence as indicated by tissue distribution and receptor occupancy studies.
JD-5037 (20 mg/kg PO) normalized triglyceride levels, liver mass and ALT as well a beneficial effect on glycemic control in model of diabetes.
M.Wt | 572.506 | |
Formula | C27H27Cl2N5O3S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: 10 mM |
|
Chemical Name/SMILES |
Butanamide, 2-[[[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[(4-chlorophenyl)sulfonyl]amino]methylene]amino]-3-methyl-, (2S)- |
1. Chorvat RJ, et al. Bioorg Med Chem Lett. 2012 Oct 1;22(19):6173-80.
2. Tam J, et al. Cell Metab. 2012 Aug 8;16(2):167-79.
3. Knani I, et al. Mol Metab. 2016 Oct 22;5(12):1187-1199.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright